Daily Mail India
People Inbox @ Single Platform

Video: Know what Union Health Minister said about COVID- 19 vaccination in India


LAST UPDATED: Dec. 21, 2020, 2:15 p.m.

NEW DELHI (DIVYA SAINI): India may start COVID- 19 vaccination in January, Union Health Minister Harsh Vardhan has said.

Harsh Vardhan said that the government’s priority is to ensure the safety and efficacy of the COVID-19 vaccine.

“I personally feel may be in January in any stage or any week, there can be a time when we can be in a position to give first COVID-19 vaccine shot to the people of India,” Harsh Vardhan said in an interview to ANI.

The minister said that the COVID-19 vaccines that have applied for emergency use authorisation are being analysed by the drug regulator.

“India is not less than any country when it comes to COVID-19 vaccine and research. Our priority has been the safety and efficacy of the vaccine. We do not want any compromise on that. Our regulators are analysing them with seriousness,” he added.

Harsh Vardhan said that the country’s health experts and scientists have worked on COVID- 19 vaccine and in the next six to seven months, India will have the capacity to vaccinate about 30 crore people of the entire country’s population.

“Our scientists and health experts have worked on the development of a vaccine by genome sequencing and isolation of the coronavirus and developed an indigenous vaccine. In 6-7 months, we will have the capacity to inoculate about 30 crore people,” he had said, addressing a ministers’ meeting on COVID-19.

There are six COVID-19 vaccine candidates in India, which are in different phases of clinical trial. The candidates of vaccine includes Covishield, Covaxin, ZyCoV-D, Sputnik V, NVX-CoV2373 and a recombinant protein antigen-based vaccine.

However, three of the COVID-19 vaccine candidates are in the pre-clinical stage of which one is in the pre-development stage, said by Union Health Secretary Rajesh Bhushan.

Earlier, the United Kingdom became the first country in the world for emergency authorization of Pfizer and BioNTech.

Image credits: Google

Source link